Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 2
2016 1
2017 1
2018 1
2019 2
2020 2
2021 2
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Elexacaftor/tezacaftor/ivacaftor in children aged 6-11 years with cystic fibrosis, at least one F508DEL allele, and advanced lung disease: A 24-week observational study.
Salvatore D, Cimino G, Troiani P, Bignamini E, Esposito I, Leonetti G, Zanda M, Manunza D, Pepe A. Salvatore D, et al. Among authors: leonetti g. Pediatr Pulmonol. 2022 Sep;57(9):2253-2256. doi: 10.1002/ppul.25980. Epub 2022 May 25. Pediatr Pulmonol. 2022. PMID: 35577767 No abstract available.
SARS-CoV-2 infection in cystic fibrosis: A multicentre prospective study with a control group, Italy, February-July 2020.
Colombo C, Alicandro G, Daccó V, Gagliano V, Morlacchi LC, Casciaro R, Pisi G, Francalanci M, Badolato R, Bignamini E, Messore B, Lucanto MC, Leonetti G, Maschio M, Cipolli M; Italian Cystic Fibrosis Society (SIFC) Study Group for COVID-19. Colombo C, et al. Among authors: leonetti g. PLoS One. 2021 May 13;16(5):e0251527. doi: 10.1371/journal.pone.0251527. eCollection 2021. PLoS One. 2021. PMID: 33984027 Free PMC article.
G-CSF and GM-CSF Modify Neutrophil Functions at Concentrations found in Cystic Fibrosis.
Castellani S, D'Oria S, Diana A, Polizzi AM, Di Gioia S, Mariggiò MA, Guerra L, Favia M, Vinella A, Leonetti G, De Venuto D, Gallo C, Montemurro P, Conese M. Castellani S, et al. Among authors: leonetti g. Sci Rep. 2019 Sep 10;9(1):12937. doi: 10.1038/s41598-019-49419-z. Sci Rep. 2019. PMID: 31506515 Free PMC article.
Clinical course and risk factors for severe COVID-19 among Italian patients with cystic fibrosis: a study within the Italian Cystic Fibrosis Society.
Colombo C, Cipolli M, Daccò V, Medino P, Alghisi F, Ambroni M, Badolato R, Battistini F, Bignamini E, Casciaro R, Ciciriello F, Collura M, Comello I, Francalanci M, Ficili F, Folino A, Leonardi S, Leonetti G, Lucanto MC, Lucca F, Maschio M, Mencarini V, Messore B, Pisi G, Pizzamiglio G, Poli P, Raia V, Riberi L, Ros M, Rotolo N, Sepe A, Taccetti G, Vitullo P, Alicandro G. Colombo C, et al. Among authors: leonetti g. Infection. 2022 Jun;50(3):671-679. doi: 10.1007/s15010-021-01737-z. Epub 2021 Dec 7. Infection. 2022. PMID: 34874541 Free PMC article.
Ivacaftor improves lung disease in patients with advanced CF carrying CFTR mutations that confer residual function.
Salvatore D, Terlizzi V, Francalanci M, Taccetti G, Messore B, Biglia C, Pisi G, Calderazzo MA, Caloiero M, Pizzamiglio G, Majo F, Cresta F, Leonetti G, De Venuto D. Salvatore D, et al. Among authors: leonetti g. Respir Med. 2020 Sep;171:106073. doi: 10.1016/j.rmed.2020.106073. Epub 2020 Jul 3. Respir Med. 2020. PMID: 32846335 Free article.
Treatment of Cystic Fibrosis Patients Homozygous for F508del with Lumacaftor-Ivacaftor (Orkambi®) Restores Defective CFTR Channel Function in Circulating Mononuclear Cells.
Favia M, Gallo C, Guerra L, De Venuto D, Diana A, Polizzi AM, Montemurro P, Mariggiò MA, Leonetti G, Manca A, Casavola V, Conese M. Favia M, et al. Among authors: leonetti g. Int J Mol Sci. 2020 Mar 31;21(7):2398. doi: 10.3390/ijms21072398. Int J Mol Sci. 2020. PMID: 32244302 Free PMC article.
14 results